Solid Therapeutics ApS: Financial statements 2022
CVR: 43007068
Source: annual report 2022, Danish Business Authority
21/01/2022 – 31/12/2022
Solid Therapeutics ApS (CVR 43007068) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -397,812 and a net result of DKK -796,818. Equity in the 2022 report amounted to DKK -756,818. The company had 1 employee in the financial year.
- Gross Profit
- DKK -397,812
- Profit/Loss
- DKK -796,818
- Equity
- DKK -756,818
- Total Assets
- DKK 3,575,234
- Employees
- 1
Keep an eye on Solid Therapeutics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of February 21, 2022, John Sørensen Haurum is registered as director of Solid Therapeutics ApS.
As of February 21, 2022, Claus Haase has stepped down as director of Solid Therapeutics ApS.
As of January 21, 2022, John Sørensen Haurum has joined the board of directors of Solid Therapeutics ApS.
As of January 21, 2022, Thue Walter Schwartz has joined the board of directors of Solid Therapeutics ApS.
As of January 21, 2022, Claus Haase has joined the board of directors of Solid Therapeutics ApS.
As of January 21, 2022, Claus Haase is registered as director of Solid Therapeutics ApS.
As of January 21, 2022, John Sørensen Haurum is registered as an owner of Solid Therapeutics ApS with an ownership share of 10%.
As of January 21, 2022, Receptor Holding ApS is registered as an owner of Solid Therapeutics ApS with an ownership share of 20%.
As of January 21, 2022, Frimurer Holdings ApS is registered as an owner of Solid Therapeutics ApS with an ownership share of 20%.
As of January 21, 2022, Haase Invest ApS is registered as an owner of Solid Therapeutics ApS with an ownership share of 10%.
About Solid Therapeutics ApS
Solid Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of John Sørensen Haurum. The company's owners include John Sørensen Haurum, Stine Helene Falsig Petersen and Anne Mette Hyldgaard Trauelsen. In 2025, the company reported a gross profit of DKK -1,687,751 and a net result of DKK -4,355,625 compared with DKK -6,758,207 the year before. Equity in the 2025 report amounted to DKK -15,353,766.